Access detailed treatment regimens for diffuse large B-cell lymphoma, such as R-CHOP with RT and radiotherapy.
Find cancer treatment regimens for hepatocellular carcinoma, including drugs such as sorafenib (Nexavar) and chemotherapy/radiotherapy clinical trials.
Get current treatment regimens for extranodal NK/T-cell lymphoma, which details options such as radiotherapy plus DeVic and SMILE + radiotherapy.
Find comprehensive treatment regimens for Hodgkin lymphoma, including therapies such as ABVD + involved-field radiotherapy and more.
PRT yields similar progression-free survival rates to IMRT; outcomes depend largely on the success of surgery prior to radiation therapy.
Clinicians ought to counsel patients that IORT can increase one's risk of ipsilateral breast tumor recurrence.
A recent study examined the efficacy of differing high-dose IMRT schedules on prostate cancer treatment.
Hypofractionated whole-breast irradiation may result in better quality of life and lower rate of acute toxic effects in breast cancer.
Whenever feasible, the use on non-neutron-producing radiotherapy is recommended.
There is a considerable gap between patient expectations and current practices for information relating to radiation use.
[Translational Cancer Research] Intraoperative radiotherapy (IORT) has emerged as a technique to deliver a single high dose of radiation to a target volume at the time of an operation.
In prostate cancer (PCa), hypofractionated radiotherapy (RT) is not non-inferior compared to standard fractionated RT.
After breast conserving surgery, standard treatment in early-stage breast cancer is adjuvant radiotherapy and endocrine treatment.
Effect of panitumumab and radiotherapy in unresected locally advanced head and neck squamous cell carcinoma.
Extranodal natural killer/ T cell lymphoma (ENKL) is a rare, but aggressive type of non-Hodgkin lymphoma.
Radiation therapists also have high coping strategy frequency; no difference in anxiety, depression, burnout, well-being compared to oncology nurses.
Findings in a quasi-experimental study of Taiwanese women with early-stage breast cancer.
Inclusion of radiotherapy with adjuvant chemotherapy improved the rate of survival in D2-resected gastric cancer.
Compared to patients who were treated with surgery alone, radiotherapy didn't increase risk for second cancers in pelvic cancers.
Accelerated partial breast irradiation (APBI) using intensity-modulation radiotherapy (IMRT) does not reduce local breast cancer recurrence.
Efficacy of definitive radiotherapy for the treatment of patients with base of the tongue cancer in a private practice evaluated.
High-dose palliative radiotherapy (HDPRT) is efficacious and safe for the treatment of localized castration-resistant prostate cancer (CRPC).
Proton beam therapy (PBT) offers clear dosimetric advantages, but it's not clear that it is superior to less expensive modalities.
ASCO released endorsement of the AUA/ASTRO prostate cancer treatment guideline regarding adjuvant and salvage radiotherapy after prostatectomy.
For Patients With a Positive Sentinel Node in Breast Cancer, Radiotherapy is Comparable to DissectionOctober 30, 2014
Radiotherapy of the axillary lymph node following a positive sentinel node effective approach in breast cancer.
Case-control studies found no evidence of neurological or cardiac impairment in children exposed to chemotherapy or radiotherapy in utero.
Similar improvement in dysphagia for radiotherapy alone, chemoradiotherapy.
Patients with Esophageal Cancer Who Receive Radiation Therapy Alone Experience Fewer Swallowing ComplicationsSeptember 15, 2014
Patients with advanced esophageal cancer who underwent radiation therapy alone experienced fewer swallowing complications.
Patients with lymphoma who receive radiation therapy have an increased survival rate.
Breast cancer is the most frequently diagnosed cancer and the second leading cause of cancer death in women.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC